Menu Search
Equities

Kontafarma China Holdings Ltd

1312:HKG.HS

Kontafarma China Holdings Ltd

Actions
  • Price (HKD)0.032
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-20.00%
  • Beta--
Data delayed at least 15 minutes, as of May 06 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kontafarma China Holdings Ltd, formely Tongfang Kontafarma Holdings Ltd, is an investment holding company principally engaged in pharmaceutical business. The Company operates its business through two business segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of prescription drugs, including chemical drugs and prescribed traditional Chinese medicines, and laboratory related products. The Fitness Business is segment is engaged in the operation of fitness centers, the provision of consultation services for fitness and health activities, as well as the operation of the franchise business for royalty fee income.

  • Revenue in HKD (TTM)809.11m
  • Net income in HKD-28.84m
  • Incorporated2011
  • Employees720.00
  • Location
    Kontafarma China Holdings Ltd9th Floor, Allied Kajima Building138 Gloucester Road, Wanchai Hong KongHKG
  • Phone+852 27316500
  • Fax+852 27316599
  • Websitehttps://www.tfkf.com.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.